ABEONA THERAPEUTICS INC. (ABEO) Return on equity 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
44.7%FY2025 · since FY2016: -22.1% → 44.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 44.7% | — |
| FY2023 | -365.5% | -217.2 pp |
| FY2022 | -148.3% | +52.1 pp |
| FY2021 | -200.5% | -118.3 pp |
| FY2020 | -82.1% | — |
| FY2018 | -42.3% | -26.2 pp |
| FY2017 | -16.1% | +6.0 pp |
| FY2016 | -22.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice